Alignment Healthcare (NASDAQ:ALHC) President Dawn Christine Maroney Sells 30,000 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $19.55, for a total value of $586,500.00. Following the completion of the transaction, the president directly owned 947,313 shares of the company’s stock, valued at $18,519,969.15. The trade was a 3.07% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Dawn Christine Maroney also recently made the following trade(s):

• On Friday, May 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $16.09, for a total value of $482,700.00.
• On Wednesday, April 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.87, for a total value of $626,100.00.
• On Wednesday, March 18th, Dawn Christine Maroney sold 36,749 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.84, for a total value of $655,602.16.

Alignment Healthcare Stock Performance

NASDAQ ALHC opened at $19.78 on Tuesday. The stock has a market capitalization of $4.09 billion, a price-to-earnings ratio of 219.78, a PEG ratio of 2.67 and a beta of 1.14. Alignment Healthcare, Inc. has a twelve month low of $11.63 and a twelve month high of $23.87. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 1.56. The stock has a 50-day moving average of $18.55 and a 200 day moving average of $19.42.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.04. The company had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.22 billion. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.Alignment Healthcare’s quarterly revenue was up 33.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.05) EPS. Sell-side analysts anticipate that Alignment Healthcare, Inc. will post 0.2 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ALHC. Raymond James Financial set a $22.00 price target on Alignment Healthcare in a report on Thursday, May 7th. Wall Street Zen upgraded Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. KeyCorp reiterated an “overweight” rating on shares of Alignment Healthcare in a research note on Wednesday, June 10th. Wolfe Research initiated coverage on Alignment Healthcare in a research note on Friday, April 17th. They set an “outperform” rating and a $24.00 price objective for the company. Finally, Barclays cut their price objective on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 26th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $24.30.

Institutional Investors Weigh In On Alignment Healthcare

Several large investors have recently bought and sold shares of ALHC. Wellington Management Group LLP increased its stake in Alignment Healthcare by 167.3% during the 3rd quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company’s stock worth $193,516,000 after buying an additional 6,940,277 shares in the last quarter. Bank of New York Mellon Corp increased its stake in Alignment Healthcare by 232.5% during the 1st quarter. Bank of New York Mellon Corp now owns 3,313,110 shares of the company’s stock worth $58,377,000 after buying an additional 2,316,777 shares in the last quarter. Invesco Ltd. increased its stake in Alignment Healthcare by 122.3% during the 2nd quarter. Invesco Ltd. now owns 4,170,529 shares of the company’s stock worth $58,387,000 after buying an additional 2,294,739 shares in the last quarter. Capital World Investors purchased a new stake in Alignment Healthcare during the 4th quarter worth approximately $44,203,000. Finally, Loomis Sayles & Co. L P purchased a new stake in shares of Alignment Healthcare in the fourth quarter valued at approximately $44,162,000. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.